-
Type 2 diabetes as well as in aging. They are targeting specific biological pathways to enhance beta cell health, testing their effects from bench to bedside, to find therapeutics to combat the disease
-
. They are targeting specific biological pathways to enhance beta cell health, testing their effects from bench to bedside, to find therapeutics to combat the disease. The lab employs a combination of cellular and
-
Study (https://record.umn.edu ). Your qualifications should include: · Ph.D. degree in genetics, genetic epidemiology, biological sciences, or a related discipline is required. · Excellent
-
cellular immunity, including antibody, B-cell, and T-cell responses. Use advanced in vivo models for vaccine and antibody testing, including conventional and humanized mice, transgenic models, rabbits, non
-
these efforts, we aim to accelerate the translation of molecular and clinical insights into tools that improve patient outcomes. More information about the lab can be found here: https://www.nathlab.org As a
-
biology. Experience working with mouse models. Experience handling large datasets. Thorough understanding of common statistical tests and distributions. Ability to collaborate with experimental and
-
assays will be used to test and refine model predictions. As a successful candidate you will: · Develop and apply computational models of adaptive oncogenesis, epithelial cell competition, and the
-
, molecular biology, cell biology, immunology, and in vivo model systems. For more information about Dr. Zhaohui Gu’s lab, please visit: https://gu-lab.net and https://www.cityofhope.org/Zhaohui-Gu As a
-
-cell sequencing, spatial sequencing, metabolism profiling, and pre-clinical drug testing in xenotransplantation models, etc. Your qualifications should include: A Ph.D. and/or M.D. degree(s), and a solid
-
response and resistance. Develop and validate predictive biomarkers of therapeutic outcomes, including blood-based genetic and epigenetic assays and methylation-based tests. Advance translational studies